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Purpose: The inner blood-retinal barrier (BRB) is a gliovascular unit in which macroglial cells surround capillary
endothelial cells and regulate retinal capillaries by paracrine interactions. The purpose of the present study was to identify
genes of retinal capillary endothelial cells whose expression is modulated by Müller glial cell-derived factors.
Methods: Conditionally immortalized rat retinal capillary endothelial (TR-iBRB2) and Müller (TR-MUL5) cell lines
were chosen as an in vitro model. TR-iBRB2 cells were incubated with conditioned medium of TR-MUL5 (MUL-CM)
for 24 h and subjected to microarray and quantitative real-time PCR analysis.
Results: TR-MUL5 cell-derived factors increased alkaline phosphatase activity in TR-iBRB2 cells, indicating that
paracrine interactions occurred between TR-iBRB2 and TR-MUL5 cells. Microarray analysis demonstrated that MUL-
CM treatment leads to a modulation of several genes including an induction of plasminogen activator inhibitor 1
(PAI-1) and a suppression of an inhibitor of DNA binding 2 (Id2) in TR-iBRB2 cells. Treatment with TGF-β1, which is
incorporated in MUL-CM, also resulted in an induction of PAI-1 and a suppression of Id2 in TR-iBRB2 cells.
Conclusions: In vitro inner BRB model study revealed that Müller glial cell-derived factors modulate endothelial cell
functions including the induction of anti-angiogenic PAI-1 and the suppression of pro-angiogenic Id2. Therefore, Müller
cells appear to be one of the modulators of retinal angiogenesis.
The  inner  blood-retinal  barrier  (inner  BRB)  is  a
selectively permeable interface between the circulating blood
and neural retina. It is essential for the maintenance of neural
functions,  since  dysfunction  of  the  inner  BRB  is  closely
involved  in  many  retinal  disorders  including  diabetic
retinopathy [1,2]. The inner BRB is formed by retinal capillary
endothelial  cells  that  exhibit  several  distinctive
characteristics,  such  as  tight  junctions  and  lack  of
fenestrations to restrict nonspecific transport. Transporters at
the inner BRB play essential roles in supplying nutrients and
are also responsible for the efflux of neurotransmitters and
their metabolites.
The inner BRB has been proposed to be a gliovascular
unit, in which macroglial cells surround retinal pericytes and
capillary endothelial cells and regulate retinal capillaries by
paracrine  interactions  [3,4].  The  vascularized  retina  of
primates and rodents contains two types of macroglial cells:
Müller  cells  and  astrocytes.  Müller  cells  are  distributed
radially across all retinal layers, whereas astrocytes are found
only on the vitreal side of the retina, within the nerve fiber and
ganglion  cell  layers.  An  in  vivo  study  demonstrated  that
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implantation of cultured Müller cells into the anterior chamber
of  the  rat  eye  induces  vessels  associated  with  implanted
Müller  cells  to  become  impermeable  to  albumin  and
horseradish peroxidase [5]. In vitro studies have shown that
the permeability of bovine retinal vascular endothelial cells is
reduced by conditioned medium from Müller cells [6,7] but
is  increased  by  matrix  metalloproteinase  9  (MMP9),  the
release of which from bovine retinal vascular endothelial cells
is stimulated by direct contact with astrocyte and Müller cells
[8]. However, the physiologic role and mechanism of the
gliovascular unit at the inner BRB is only beginning to be
understood.
The  purpose  of  the  present  study  was  to  identify
differently expressed genes of retinal capillary endothelial
cells in response to Müller cell-derived factors by performing
a microarray analysis, which allows the detection of over
15,000  transcripts.  Conditionally  immortalized  rat  retinal
capillary endothelial (TR-iBRB2) and Müller (TR-MUL5)
cell lines were chosen as an in vitro model, since these cell
lines maintain certain in vivo functions and are of the same
maturational  stage,  strain,  and  genetic  background  [9,10].
Using  these  culture  cell  lines,  it  is  possible  to  overcome
problems posed by contamination by other types of cells,
species differences, and the limited size of the organs.
METHODS
Cell  culture:  TR-iBRB2  cells  are  a  conditionally
immortalized rat retinal capillary endothelial cell line and TR-
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451MUL5  cells  are  a  conditionally  immortalized  rat  retinal
Müller  cell  line.  Both  cell  lines  were  established  from
transgenic rats harboring a temperature-sensitive SV 40 large
T-antigen gene [9,10]. TR-iBRB2 cells possess endothelial
markers and facilitative glucose transporter 1, P-glycoprotein,
creatine transporter, and L-type amino acid transporter 1 that
are expressed at the inner BRB in vivo [10-12]. TR-MUL5
cells  possess  typical  Müller  cell  markers,  such  as  S-100,
glutamine synthetase, and excitatory amino acid transporter 1
[9,13,14].  These  cell  lines  were  cultured  in  Dulbecco’s
modified Eagle’s medium (DMEM; Nissui Pharmaceuticals,
Tokyo, Japan) supplemented with 10% fetal bovine serum
(FBS; Moregate, Bulimbra, Australia) at 33 °C in a humidified
atmosphere of 5% CO2/air. The permissive temperature for
these cell lines to be cultured was 33 °C, due to the presence
Figure 1. In vitro cell culture models. These models were used for
analyzing paracrine interactions between retinal capillary endothelial
and Müller cells. A: In the transfilter co-culture, TR-MUL5 cells
were situated on the basolateral aspect of TR-iBRB2 cells monolayer
as might occur in vivo. B: The fivefold concentrated conditioned
medium of TR-MUL5 cells (MUL-CM) was applied to TR-iBRB2
cells.
of temperature-sensitive SV40 large T-antigen. TR-iBRB2
cells were seeded onto a rat tail collagen type I-coated tissue
culture dish (BD Biosciences, Bedford, MA).
Interaction  with  TR-MUL5  cells  and  TGF-β1:  In  the
transfilter co-culture, TR-MUL5 cells were seeded on the
backside membrane of a rat tail collagen type I-coated cell
culture insert (pore side: 3.0 μm, BD Biosciences) (Figure
1A). After a 24 h culture, the insert was transferred to a six
well tissue culture plate. TR-iBRB2 cells were seeded on the
upper side of the insert and were co-cultured for 6 days.
Conditioned medium of TR-MUL5 cells was prepared by
incubating 4 ml of serum-free DMEM with TR-MUL5 cells
for 24 h onto a 100 mm tissue culture dish (Figure 1B) [15,
16]. The conditioned medium was passed through a 0.22 μm
filter, concentrated up to 20 fold in a Centriprep or a Microcon
(3 kDa cut-off; Millipore, Billerica, MA), and then stored at
−20 °C until required. The conditioned medium was adjusted
to fivefold concentrated conditioned medium of TR-MUL5
cells  (MUL-CM)  by  diluting  the  20  fold  concentrated
conditioned  medium  with  serum-free  DMEM.  TR-iBRB2
cells  were  then  treated  with  MUL-CM  or  2  ng/ml  of
recombinant human transforming growth factor β1 (TGF-β1;
R&D  Systems,  Minneapolis,  MN),  which  shows  111/112
amino acid sequence identity with rat TGF-β1, for 24 h. It is
demonstrated that 2 ng/ml human TGF-β increased MMP9
activity and the permeability of primary cultures of bovine
retinal endothelial cells. Therefore, we chose the 2 ng/ml as a
concentration of TGF-β1.
Alkaline  phosphatase  activity:  The  alkaline  phosphatase
activity in TR-iBRB2 cells was measured using an alkaline
phosphatase test kit (Wako Pure Chemicals, Osaka, Japan)
according to the manufacturer’s protocol. Briefly, TR-iBRB2
cells  were  dissolved  in  phosphate  buffered  saline  (PBS;
137  mM  NaCl,  8.10  mM  Na2HPO4,  2.68  mM  KCl,  and
1.47 mM KH2PO4) containing 0.5% Triton-X. Cell lysate was
mixed with p-nitrophenyl phosphate in reaction buffer (pH
9.8) and was incubated at 37 °C for 15 min. p-Nitrophenyl
phosphate is hydrolyzed into p-nitrophenol in the presence of
alkaline  phosphatase.  Subsequently,  the  reaction  was
terminated  by  adding  NaOH  and  the  absorbance  was
measured at 405 nm. Protein concentrations were determined
using a DC protein assay kit (Bio-Rad, Hercules, CA).
Microarray:  A  GeneChip  Rat  Expression  Array  230A
(Affymetrix,  Santa  Clara,  CA),  which  consists  of  15,866
probe sets, was used in this experiment. Total cellular RNA
was extracted from TR-iBRB2 cells using an RNeasy kit
(Qiagen, Hilden, Germany) according to the manufacturer’s
protocol. Poly(A)+ RNA was purified from total cellular RNA
using  Oligotex-dT30  super  (Takara,  Shiga,  Japan)  and
cleaned  by  phenol/chloroform  extraction.  A  T7-(dT)24
oligomer,  superscript  reverse  transcriptase  II,  and  DNA
Polymerase I (Invitrogen, Carlsbad, CA) were used for first-
strand  and  second-strand  cDNA  synthesis  using  Poly(A)+
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Phase Lock Gels-Phenol/Chloroform extraction and ethanol
precipitation. Biotin-labeled antisense cRNA was produced
by an in vitro transcription reaction (Enzo BioArray High
Yield  RNA  Transcript  Labeling  Kit;  Affymetrix)  and
incubated  with  fragmentation  buffer.  Fragmented  biotin-
labeled antisense cRNA was hybridized to the GeneChip in a
GeneChip hybridization oven (Affymetrix). The hybridized
GeneChip was washed and stained using a GeneChip fluidics
station 400 (Affymetrix) and was then scanned by a GeneChip
scanner (Affymetrix). The definitions of presence and absence
of gene expression were defined by the Affymetrix GCOS 1.2
statistical  algorithm.  Gene  expression  analyses,  including
global normalization and scaling, were performed using the
Affymetrix GCOS 1.2, Array Assist 3.01 software.
Figure 2. Alkaline phosphatase activity in TR-iBRB2 cells. Effects
of transfilter co-culture with TR-MUL5 cells (A) and soluble factors
secreted  from  TR-MUL5  cells  (B)  on  the  activity  of  alkaline
phosphatase in TR-iBRB2 cells. A: TR-MUL5 cells were situated
on the basolateral aspect of TR-iBRB2 cell monolayers as might
occur in vivo and cells were co-cultured for six days. B: TR-iBRB2
cells were cultured in the conditioned medium of TR-MUL5 cells
(MUL-CM) for 24 h. Each column represents the mean±SEM (n=3).
Asterisk represents p<0.01, significantly different from the control.
Immunoblot analysis: Protein concentrations of MUL-CM
were determined using a DC protein assay kit. The MUL-CM
was  mixed  with  sample  buffer  composed  of  2%  sodium
dodecyl  sulfate  (SDS),  50  mM  Tris-HCl  (pH  6.8),  10%
glycerol,  6%  2-mercaptoethanol,  and  0.01%  bromophenol
blue. The mixture was heated for 10 min at 95 °C. Next,
100 μg protein of MUL-CM was electrophoresed on an SDS-
polyacrylamide gel and, subsequently, electrotransferred to a
polyvinylidene difluoride membrane. Following incubation
with  blocking  agent  solution  (Block  Ace;  Dainihon
Pharmaceutical,  Osaka,  Japan),  the  membranes  were
incubated  with  1:300  mouse  monoclonal  anti-TGF-β1
antibody (R&D Systems) for 16 h at 4 °C. The membranes
were  subsequently  incubated  with  horseradish  peroxidase
conjugated anti-mouse IgG. The bands were visualized using
an  enhanced  chemiluminescence  kit  (GE  Healthcare,
Piscataway, NJ).
Quantitative  real-time  PCR:  Quantitative  real-time
polymerase chain reaction (PCR) was performed using an
ABI  PRISM  7700  sequence  detector  system  (Applied
Biosystems, Foster City, CA) with 2×5 ml SYBR Green PCR
Master  Mix  (Applied  Biosystems)  according  to  the
manufacturer’s protocol. Single-strand cDNA was made from
total cellular RNA by reverse transcription (RT) using oligo
dT primer. The control lacking the RT enzyme was assayed
in parallel to monitor any possible genomic contamination. To
quantify the amount of specific mRNA in the samples, we
generated a standard curve for each run using the plasmid
(pGEM-T Easy Vector; Promega, Madison, WI) containing
the gene of interest. This enabled standardization of the initial
mRNA content of cells relative to the amount of β-actin. The
PCR was performed with plasminogen activator inhibitor 1
(PAI-1), inhibitor of DNA binding 2 (Id2), or β-actin specific
primers (Table 1) through 40 cycles of 94 °C for 30 s, 60 °C
for  30  s,  and  72  °C  for  1  min.  The  PCR  products  were
separated by electrophoresis on an agarose gel and visualized
under ultraviolet light to confirm the specificity of the primers
for the target gene.
Data analysis: Unless otherwise indicated, all data represent
mean±SEM. An unpaired, two-tailed Student's t-test was used
to  determine  the  significance  of  differences  between  two
groups. Statistical significance of differences among means
of  several  groups  was  determined  by  one-way  ANOVA
TABLE 1. OLIGONUCLEOTIDE PRIMERS USED FOR PCR AMPLIFICATION OF CDNAS.
Target mRNA Accession number                         Primers (5′-3′) Product size
PAI-1 NM_012620 F: GAGGATGAAAGAAACAGCCAGCT 145 bp
R: CCCGCTATGAAATTAGATTCACGT
Id2 NM_013060 F: ATGAAAGCCTTCAGTCCGGTGAG 405 bp
R: TTAGCCACAGAGTACTTTGCTGTCA
β-actin NM_031144 F: TCATGAAGTGTGACGTTGACATCCGT 285 bp
R: CCTAGAAGCATTTGCGGTGCACGATG
Primers were used for the determination of mRNA expression levels in TR-iBRB2 cells by quantitative real-time PCR analysis.
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method.
RESULTS
Alkaline phosphatase in endothelial cells is induced by glial
cells  [17,18].  To  determine  whether  interactions  occur
between TR-iBRB2 cells and TR-MUL5 cells, we examined
the effects of transfilter co-culture with TR-MUL5 cells and
soluble factors secreted from TR-MUL5 cells on the activity
of alkaline phosphatase in TR-iBRB2 cells. In the transfilter
co-culture, TR-MUL5 cells were situated on the basolateral
aspect of the TR-iBRB2 cell monolayer as might occur in vivo
(Figure 1A) and cells were cocultured for six days. The effect
of  soluble  factors  secreted  from  TR-MUL5  cells  were
examined  by  culturing  TR-iBRB2  cells  in  fivefold
concentrated conditioned medium of TR-MUL5 cells (MUL-
CM) for 24 h (Figure 1B). As shown in Figure 2, alkaline
phosphatase  activity  in  TR-iBRB2  cells  was  significantly
increased to 153% by coculture with TR-MUL5 cells and
222% by coculture with MUL-CM cells.
To  identify  genes,  the  expressions  of  which  are
modulated by soluble factors secreted from TR-MUL5 cells,
we incubated TR-iBRB2 cells with MUL-CM for 24 h and
subjected them to microarray analysis for genome-wide gene
expression profiling. We compared the gene expression levels
between  control  and  MUL-CM  treatment  groups  and
identified genes showing differential expression with at least
a threefold change. As shown in Table 2, MUL-CM treatment
induced the expression of five genes, namely, myosin heavy
chain  polypeptide  6  (Myh6),  retinol  binding  protein  1
(Rbp1),  metallothionein  1a  (Mt1a),  ectonucleotide
pyrophosphatase/phosphodiesterase  1  (Enpp1),  and
plasminogen activator inhibitor 1 (PAI-1), and suppressed the
expression of an inhibitor of DNA binding 2 (Id2) gene.
PAI-1 and Id2 are anti-angiogenic and pro-angiogenic
factors,  respectively,  but  both  proteins  are  regulated  by
transforming growth factor β (TGF-β) signaling pathways in
endothelial cells [19-21]. The expression of TGF-β1 protein
in  MUL-CM  was  examined  by  immunoblot  analysis.  As
shown in Figure 3A, a band around 12.5 kDa was detected in
MUL-CM,  indicating  that  TR-MUL5  cells  secret  TGF-β1
protein. Quantitative real-time PCR analysis was performed
to confirm the effect of TGF-β1 on the expression of PAI-1
and  Id2  mRNAs  in  TR-iBRB2  cells  (Figures  3B,C).
Treatment with 2 ng/ml recombinant human TGF-β1 for 24 h
resulted  in  an  increase  in  PAI-1  mRNA  of  520%  and  a
decrease in Id2 mRNA of 93.2%. These data are consistent
with  TR-iBRB2  cells  incubated  with  MUL-CM  for  24  h
(122% increase in PAI-1 and 70.8% decrease in Id2).
DISCUSSION
The present study demonstrated that TR-MUL5 cell-derived
factors  modulate  alkaline  phosphatase  activity  and  the
expression of several genes including PAI-1 and Id2 in TR-
iBRB2  cells.  Endothelial  cells  that  are  present  in  the
gliovascular unit (e.g., blood-brain barrier [BBB] and inner
BRB)  are  known  to  be  especially  abundant  in  alkaline
phosphatase  [22].  The  observed  induction  of  alkaline
phosphatase in TR-iBRB2 cells by TR-MUL5 cell-derived
factor (Figure 2) suggested that our cell culture model of the
inner BRB is appropriate for the analysis of the paracrine
interaction between Müller and retinal capillary endothelial
cells. Moreover, both co-culture with TR-MUL5 cells and
MUL-CM  induced  alkaline  phosphatase  activity  in  TR-
iBRB2 cells (Figure 2), implying that the diffusive signal is
predominantly  involved  in  the  induction  of  alkaline
phosphatase at the inner BRB. This is consistent with studies
using in vitro cell culture models of the BBB, in which a
diffusive  signal  by  glia-derived  factors,  including  basic
fibroblast growth factor, is suggested to induce endothelial
alkaline  phosphatase  [17,18].  Following  treatment  with
MUL-CM,  TR-iBRB2  cells  increased  the  expression  of
Enpp1 (Table 2). Enpp1 and alkaline phosphatase overlap in
phosphatase  function  as  well  as  act  together  in  the
extracellular hydrolysis of ATP to inorganic phosphate [23,
24].  Therefore,  Enpp1  might  contribute  the  induction  of
alkaline  phosphatase  by  MUL-CM  via  its  phosphatase
activity.
Microarray analysis demonstrated that PAI-1 and Id2 in
TR-iBRB2 cells are respectively induced and suppressed by
TABLE 2. GENES MODULATED BY TR-MUL5 CONDITIONED MEDIUM IN TR-IBRB2 CELLS
Gene Accession number                                   Fold change
Myosin heavy chain polypeptide 6 (Myh6) NM_017239 16
Retinol binding protein 1 (Rbp1) NM_012733 5.3
Metallothionein 1a (Mt1a) NM_138826 5.3
Ectonucleotide pyrophosphatase/phosphodiesterase 1 (Enpp1) NM_053535 4.9
Plasminogen activator inhibitor 1 (PAI-1) NM_012620 3.5
Inhibitor of DNA binding 2 (Id2) NM_013060 0.23
TR-iBRB2 cells were incubated with MUL-CM for 24 h and subjected them to microarray analysis. We compared the gene
expression  levels between control and MUL-CM treatment groups and identified genes showing differential expression with at
least a threefold change.
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454Figure 3. TGF-β, PAI-1, and Id2 expressions. Expression of TGF-
β1 in the conditioned medium of TR-MUL5 cells (MUL-CM) (A)
and modulation of PAI-1 (B) and Id2 (C) mRNA expressions by
recombinant  human  TGF-β1  (rhTGF-β1)  and  MUL-CM  in  TR-
iBRB2  cells.  A:  The  expression  of  TGF-β1  was  determined  by
immunoblot analysis. B, C: The expression levels of PAI-1 and Id2
mRNA were determined by quantitative real-time PCR analysis and
normalized to β-actin mRNA expression. Each column represents
the mean±SEM (n=4–12). Asterisk represents p<0.01, significantly
different from the control.
MUL-CM  (Table  2),  which  is  further  confirmed  by
quantitative  real-time  PCR  analysis  (Figure  3).  We  also
demonstrated  that  PAI-1  and  Id2  in  TR-iBRB2  cells  are
respectively  induced  and  suppressed  by  TGF-β1  (Figures
3B,C), which is seen to be secreted from TR-MUL5 cells
(Figure 3A). In agreement with our results, it has already
shown that TGF-β is secreted from rat [25] and human [26]
Müller cells. These results raise the possibility that Müller
cells  may  modulate  retinal  angiogenesis  by  altering  its
secretion of TGF-β1, although further studies are needed to
confirm the involvement of TGF-β1 as a paracrine factor
between Müller and endothelial cells. It is also necessary to
determine  the  effect  of  MUL-CM  and  TGF-β1  on  cell
migration and proliferation in TR-iBRB2 cells.
Myh6 encodes the cardiac α-myosin heavy chain and its
expression  is  reported  to  be  induced  by  TGF-β  signaling
pathways  in  cardiomyocytes  during  embryonic  heart
development [27], but the physiologic significance of Myh6
in retinal endothelial cells still needs to be clarified. Rbp1 in
cultured hepatic stellate and fibroblast cells [28,29] and Mt1a
in retinal pigment epithelial cells [30] are induced by TGF-β.
Rbp1 binds to retinol in the cytoplasm and is involved in the
intracellular transport of retinol in a variety of cells including
retinal pigment epithelial cells. Mt1a protects cells against
oxidative stress and apoptosis in the retina. Enpp1 is induced
by TGF-β and bFGF in osteosarcoma cells [31,32]. Therefore,
paracrine interactions between Müller and endothelial cells
seem  to  play  an  important  role  in  modulating  several
functions, such as intracellular retinol transport and protection
against oxidative stress, in retinal capillary endothelial cells.
In conclusion, Müller cells appear to act as one of the
modulators  of  retinal  angiogenesis  and  TGF-β  may  be
involved in this modulation. To our knowledge, this is the first
report to suggest that Müller cells modulate the expression of
PAI-1 and Id2 in retinal endothelial cells. As the number of
diabetic patients is increasing throughout the world, acquired
blindness in diabetic retinopathy is a serious problem. The
current  findings  offer  important  information  for  a  better
understanding of the mechanism of retinal neovascularization
which  is  a  common  pathological  finding  in  diabetic
retinopathy.
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